Jeffrey Weiss, MD | |
851 Westpoint Dr, B10, Wasilla, AK 99654-7142 | |
(907) 357-2800 | |
(907) 357-2801 |
Full Name | Jeffrey Weiss |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 34 Years |
Location | 851 Westpoint Dr, Wasilla, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215908207 | NPI | - | NPPES |
MD09481 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 4222 (Alaska) | Primary |
Entity Name | Valley Dermatology Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821093550 PECOS PAC ID: 3476440603 Enrollment ID: O20040302001350 |
News Archive
The test strips being recalled may give falsely low blood glucose results. False results may lead patients to try to raise their blood glucose unnecessarily, or they may fail to treat elevated blood glucose because of a false, low reading. Both scenarios pose risks to a patient's health.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
Karolinska Development (publ), managing one of the largest portfolios of life science research companies in Europe, announced that XSpray Microparticles AB has launched a GMP production facility in Malmo, Sweden. In addition to offering particle development and characterization services, XSpray can now provide customers with high quality drug particles and powders for use in their clinical studies.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey Weiss, MD 851 E Westpoint Dr, B10, Wasilla, AK 99654 Ph: (907) 357-2800 | Jeffrey Weiss, MD 851 Westpoint Dr, B10, Wasilla, AK 99654-7142 Ph: (907) 357-2800 |
News Archive
The test strips being recalled may give falsely low blood glucose results. False results may lead patients to try to raise their blood glucose unnecessarily, or they may fail to treat elevated blood glucose because of a false, low reading. Both scenarios pose risks to a patient's health.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
Karolinska Development (publ), managing one of the largest portfolios of life science research companies in Europe, announced that XSpray Microparticles AB has launched a GMP production facility in Malmo, Sweden. In addition to offering particle development and characterization services, XSpray can now provide customers with high quality drug particles and powders for use in their clinical studies.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 3 days ago
Dr. Blake Galler, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3066 E Meridian Park Loop, Wasilla, AK 99654 Phone: 907-357-9590 Fax: 907-357-9593 |